Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL473P, also known as RNA, 7SL, cytoplasmic 473, pseudogene, is classified as a pseudogene of the 7SL RNA, which is an RNA component of the signal recognition particle (SRP)[1][3][5][8]. Unlike functional protein-coding genes or therapeutic targets, pseudogenes like RN7SL473P are generally considered non-functional remnants of once-active genes; they arise through retrotransposition or gene duplication, and the majority do not encode functional RNA or protein products[1][5][8]. The parent 7SL RNA serves as a scaffold RNA for the SRP complex in protein targeting within the cell, but RN7SL473P itself does not participate in this process[7][1]. A large number of such 7SL RNA-related pseudogenes exist in the human genome; they are not actively transcribed or translated, and they do not have any known therapeutic relevance, mechanism of drug action, or established use as biomarkers. The gene is clearly annotated as a pseudogene and is not considered a therapeutic, diagnostic, or research target in current biomedical contexts[1][5][8]. There is nothing to indicate that "RNA, 7SL, cytoplasmic 473, pseudogene" is a misspelling, but it is not a targetable molecule in drug discovery or clinical applications[1][7][8]. If you require structured information for protein-coding members of the SRP RNA family, refer to the functional 7SL RNA genes (such as RN7SL1) rather than this pseudogene locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 473, pseudogene (RN7SL473P).